Ignite Creation Date:
2024-05-06 @ 4:07 PM
Last Modification Date:
2024-10-26 @ 2:04 PM
Study NCT ID:
NCT04877899
Status:
UNKNOWN
Last Update Posted:
2021-09-05
First Post:
2021-04-22
Brief Title:
Mazankowski Alberta Heart Institute MAHI EchoGo Discovery 1 Protocol
Sponsor:
Ultromics Ltd
Organization:
Ultromics Ltd
Study Overview
Official Title:
Mazankowski - Echo Go Discovery Protocol Retrospective LVEFGLS Comparison
Status:
UNKNOWN
Status Verified Date:
2021-09
Last Known Status:
ENROLLING_BY_INVITATION
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to compare conventionally acquired Left Ventricle Ejection Fraction LVEF and Global Longitudinal Strain GLS data to Artificial Intelligence AI driven automated processing of 2 dimensional contrast and 2 dimensional non-contrast resting transthoracic echocardiograms for application in the assessment of patients undergoing chemotherapy with cardiotoxic drugs This is a single-centre retrospective study which utilizes echocardiographic DICOM image and meta-data datasets received from a Canadian site Data processed using the AI driven automated processing will be compared to conventionally acquired LVEF and GLS measurements and results will be analysed to determine accuracy and precision
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None